About SYNAPTONE, INC
SynaptONE is a company focused on central nervous system innovation through neuroactive steroids as therapeutic targets for affective disorders. The company aims to develop effective, safe, and personalized treatments by modulating neural activity and supporting neuroplasticity.
Research and development of novel compounds targeting neuroactive steroidsLeveraging neurosteroid signaling pathways for neuropsychiatric therapeuticsDesigning precision medicine strategies for conditions like depression, anxiety, schizophrenia, and PTSD
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to SYNAPTONE, INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.